Sally M. Hunter

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes

Sally M. Hunter · Oncotarget · 2015 · 195 citations · Full text

Genetics, Gynecology, Pathology +16

The molecular origin and taxonomy of mucinous ovarian carcinoma

Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland et al. · Nature Communications · 2019 · 180 citations · Full text

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

Gail P. Risbridger, Renea A. Taylor, David Clouston et al. · European Urology · 2014 · 135 citations

Urology, Patient-derived Xenografts, Cancer Pathology +8

Thymic lymphomas in mice with a truncating mutation in Brca2.

Lori S. Friedman, Fiona Thistlethwaite, Khyati Patel et al. · PubMed · 1998 · 132 citations

Lymphoid Neoplasia, Genome Instability, Genetics +14

<i><scp>RNF43</scp></i> is a tumour suppressor gene mutated in mucinous tumours of the ovary

Georgina L. Ryland, Sally M. Hunter, Maria Doyle et al. · The Journal of Pathology · 2012 · 117 citations